India MCA Insolvency Liquidation Filings — May 11, 2026
Across 11 filings in the India MCA Insolvency & Restructuring Monitor, key themes include accelerating resolution plan approvals (4/11 cases positive: Kobo Biotech, Morarjee Textiles, Gabriel India), ongoing CIRP proceedings with upcoming hearings (Vikas WSP, Vas Infrastructure), merger/amalgamation schemes advancing (Dr. Agarwals entities, Asian Energy Services), and new distress signals (Cerebra Integrated, SKIL Infrastructure). No explicit YoY/QoQ financial trends available, but operational metrics highlight distress outliers like SKIL's NIL sales/zero fixed assets last FY vs. Kobo's Rs.70.11 Cr resolution payouts. Positive sentiments dominate resolved cases (3/11 explicitly positive), signaling potential value recovery, while negative cases (2/11) flag deepening insolvency risks. Portfolio-level pattern: Infra sector (Vas, SKIL) shows prolonged CIRP with weak ops; healthcare/energy schemes offer restructuring catalysts. Market implications: Turnaround opportunities in approved resolutions amid IBC process efficiencies, but avoid new CIRP initiations; catalyst-dense May-June 2026 with 7+ hearings/meetings.